Additional caution was engendered when the CLASS study demonstrated that the advantage of celecoxib in preventing GI complications was offset when low-dose aspirin was used simultaneously.
Celecoxib is safer for the stomach than standard NSAIDs, but if the patient is also taking aspirin (even baby aspirin), the GI safety advantage is lost.